A PDGFR-β-specific shRNA can reduce viability and enhance GBM radiosensitivity [70], and silencing PDGFRB by RNAi was shown to enhance the radiosensitivity of C6 glioma cells in vivo [70]. The gene discussed is PDGFRB; the disease is central nervous system cancer.